Works matching AU Kobe, Carsten


Results: 81
    1

    Implementation of PET/CT in radiation oncology—a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology.

    Published in:
    Strahlentherapie und Onkologie, 2024, v. 200, n. 11, p. 931, doi. 10.1007/s00066-024-02260-4
    By:
    • Wegen, Simone;
    • Nestle, Ursula;
    • Zamboglou, Constantinos;
    • Spohn, Simon K. B.;
    • Nicolay, Nils Henrik;
    • Unterrainer, Lena M.;
    • Koerber, Stefan A.;
    • La Fougère, Christian;
    • Fokas, Emmanouil;
    • Kobe, Carsten;
    • Eze, Chukwuka;
    • Grosu, Anca-Ligia;
    • Fendler, Wolfgang P.;
    • Holzgreve, Adrien;
    • Werner, Rudolf;
    • Schmidt-Hegemann, Nina-Sophie
    Publication type:
    Article
    2

    Dual-tracer PET/CT protocol with [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [<sup>18</sup>F]FDG in different cancer types, resulting in larger functional and gross tumor volume.

    Published in:
    Strahlentherapie und Onkologie, 2024, v. 200, n. 1, p. 28, doi. 10.1007/s00066-023-02117-2
    By:
    • Wegen, Simone;
    • Weindler, Jasmin;
    • Voltin, Conrad-Amadeus;
    • van Heek, Lutz;
    • Schomäcker, Klaus;
    • Fischer, Thomas;
    • Marnitz, Simone;
    • Kobe, Carsten;
    • Drzezga, Alexander;
    • Roth, Katrin S.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 1, p. e5, doi. 10.1111/bjh.17997
    By:
    • Kreissl, Stefanie;
    • Voltin, Conrad‐Amadeus;
    • Kaul, Helen;
    • Bühnen, Ina;
    • Mettler, Jasmin;
    • Pabst, Thomas;
    • Eichenauer, Dennis A.;
    • Fuchs, Michael;
    • Diehl, Volker;
    • Dietlein, Markus;
    • Engert, Andreas;
    • Borchmann, Peter;
    • Kobe, Carsten
    Publication type:
    Article
    10

    Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 3, p. 606, doi. 10.1111/bjh.17878
    By:
    • Gillessen, Sarah;
    • Hüttmann, Andreas;
    • Vucinic, Vladan;
    • Müller, Horst;
    • Plütschow, Annette;
    • Viardot, Andreas;
    • Topp, Max S.;
    • Kobe, Carsten;
    • Böll, Boris;
    • Eichenauer, Dennis A.;
    • Sasse, Stephanie;
    • Haverkamp, Heinz;
    • Schmitz, Christine;
    • Borchmann, Sven;
    • Bröckelmann, Paul J.;
    • Heger, Jan‐Michel;
    • Fuchs, Michael;
    • Engert, Andreas;
    • Borchmann, Peter;
    • von Tresckow, Bastian
    Publication type:
    Article
    11

    Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.

    Published in:
    British Journal of Haematology, 2015, v. 171, n. 4, p. 547, doi. 10.1111/bjh.13646
    By:
    • Bröckelmann, Paul J.;
    • Goergen, Helen;
    • Fuchs, Michael;
    • Kriz, Jan;
    • Semrau, Robert;
    • Baues, Christian;
    • Kobe, Carsten;
    • Behringer, Karolin;
    • Eichenauer, Dennis A.;
    • Tresckow, Bastian;
    • Klimm, Beate;
    • Halbsguth, Teresa;
    • Wongso, Diana;
    • Plütschow, Annette;
    • Haverkamp, Heinz;
    • Dietlein, Markus;
    • Eich, Hans T.;
    • Stein, Harald;
    • Diehl, Volker;
    • Borchmann, Peter
    Publication type:
    Article
    12

    PET-guided Treatment in Patients with Advanced-stage Hodgkin's Lymphoma (HD18): Final Results of An Open-label, International, Randomised Phase 3 Trial by the German Hodgkin Study Group.

    Published in:
    Indian Journal of Chest Diseases & Allied Sciences, 2018, v. 60, n. 1, p. 44
    By:
    • Borchmann, Peter;
    • Goergen, Helen;
    • Kobe, Carsten;
    • Lohri, Andreas;
    • Greil, Richard;
    • Eichenauer, Dennis A.;
    • Zijlstra, Josée M.;
    • Markova, Jana;
    • Meissner, Julia;
    • Feuring-Buske, Michaela;
    • Hüttmann, Andreas;
    • Dierlamm, Judith;
    • Soekler, Martin;
    • Beck, Hans-Joachim;
    • Willenbacher, Wolfgang;
    • Ludwig, Wolf-Dieter;
    • Pabst, Thomas;
    • Topp, Max S.;
    • Hitz, Felicitas;
    • Bentz, Martin
    Publication type:
    Article
    13

    Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 4, p. 801, doi. 10.1002/hon.2986
    By:
    • Eichenauer, Dennis A.;
    • Bühnen, Ina;
    • Plütschow, Annette;
    • Kobe, Carsten;
    • Dietlein, Markus;
    • Wendtner, Clemens‐Martin;
    • Thorspecken, Sven;
    • Topp, Max S.;
    • Mauser, Mareike;
    • von Tresckow, Bastian;
    • Fuchs, Michael;
    • Borchmann, Peter;
    • Engert, Andreas
    Publication type:
    Article
    14

    S218: CORRELATION BETWEEN PROGRESSION‐FREE AND OVERALL SURVIVAL IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: A COMPREHENSIVE ANALYSIS OF INDIVIDUAL PATIENT DATA FROM RANDOMIZED GHSG TRIALS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967784.58441.b3
    By:
    • Bröckelmann, Paul;
    • Müller, Horst;
    • Gillessen, Sarah;
    • Jacob, Anne Sophie;
    • Momotow, Jesko;
    • Damaschin, Carla;
    • Ferdinandus, Justin;
    • Yang, Xiaoqin;
    • Fuchs, Michael;
    • Kobe, Carsten;
    • Eich, Hans T.;
    • Engert, Andreas;
    • Borchmann, Peter;
    • Von Tresckow, Bastian
    Publication type:
    Article
    15

    Outcome Prediction in Patients With Large B‐cell Lymphoma Undergoing Chimeric Antigen Receptor T‐cell Therapy.

    Published in:
    HemaSphere, 2023, v. 7, n. 1, p. e817, doi. 10.1097/HS9.0000000000000817
    By:
    • Voltin, Conrad‐Amadeus;
    • Gödel, Philipp;
    • Beckmann, Laura;
    • Heger, Jan‐Michel;
    • Kobe, Carsten;
    • Kutsch, Nadine;
    • Borchmann, Peter;
    • Dietlein, Markus;
    • Herrmann, Ken;
    • Stelljes, Matthias;
    • Rahbar, Kambiz;
    • Lenz, Georg;
    • Reinhardt, H. Christian;
    • Teichert, Marcel;
    • Noppeney, Richard;
    • Albring, Jörn C.;
    • Seifert, Robert;
    • von Tresckow, Bastian;
    • Flossdorf, Sarah;
    • Hanoun, Christine
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer.

    Published in:
    EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0540-7
    By:
    • Hohberg, Melanie;
    • Kobe, Carsten;
    • Krapf, Philipp;
    • Täger, Philipp;
    • Hammes, Jochen;
    • Dietlein, Felix;
    • Zlatopolskiy, Boris D.;
    • Endepols, Heike;
    • Wild, Markus;
    • Neubauer, Stephan;
    • Heidenreich, Axel;
    • Neumaier, Bernd;
    • Drzezga, Alexander;
    • Dietlein, Markus
    Publication type:
    Article
    22
    23

    Role of [18F]-fluoro-2-deoxy- d-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 1, p. 64, doi. 10.3109/10428194.2011.603444
    By:
    • Markova, Jana;
    • Kahraman, Deniz;
    • Kobe, Carsten;
    • Skopalova, Magdalena;
    • Mocikova, Heidi;
    • Klaskova, Katerina;
    • Dedeckova, Katerina;
    • Eich, Hans-Theodor;
    • Böll, Boris;
    • Dietlein, Markus;
    • Kozak, Tomas
    Publication type:
    Article
    24
    25

    Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00241-9
    By:
    • Schaufler, Diana;
    • Ast, David F.;
    • Tumbrink, Hannah L.;
    • Abedpour, Nima;
    • Maas, Lukas;
    • Schwäbe, Ayla E.;
    • Spille, Inga;
    • Lennartz, Stefanie;
    • Fassunke, Jana;
    • Aldea, Mihaela;
    • Besse, Benjamin;
    • Planchard, David;
    • Nogova, Lucia;
    • Michels, Sebastian;
    • Kobe, Carsten;
    • Persigehl, Thorsten;
    • Westphal, Theresa;
    • Koleczko, Sophia;
    • Fischer, Rieke;
    • Weber, Jan-Phillip
    Publication type:
    Article
    26

    Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 14, p. 4991, doi. 10.1002/cam4.3131
    By:
    • Nogova, Lucia;
    • Mattonet, Christian;
    • Scheffler, Matthias;
    • Taubert, Max;
    • Gardizi, Masyar;
    • Sos, Martin L.;
    • Michels, Sebastian;
    • Fischer, Rieke N.;
    • Limburg, Meike;
    • Abdulla, Diana S.Y.;
    • Persigehl, Thorsten;
    • Kobe, Carsten;
    • Merkelbach‐Bruse, Sabine;
    • Franklin, Jeremy;
    • Backes, Heiko;
    • Schnell, Roland;
    • Behringer, Dirk;
    • Kaminsky, Britta;
    • Eichstaedt, Martina;
    • Stelzer, Christoph
    Publication type:
    Article
    27
    28
    29

    Mean and maximum standardized uptake values in [<sup>18</sup>F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 5, p. 735, doi. 10.1007/s00259-008-1011-y
    By:
    • Schmidt, Matthias;
    • Bollschweiler, Elfriede;
    • Dietlein, Markus;
    • Mönig, Stefan;
    • Kobe, Carsten;
    • Vallboehmer, Daniel;
    • Eschner, Wolfgang;
    • Hölscher, Arnulf;
    • Schicha, Harald
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early‐stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 6, p. 881, doi. 10.1111/ejh.14093
    By:
    • van Heek, Lutz;
    • Weindler, Jasmin;
    • Gorniak, Claudia;
    • Kaul, Helen;
    • Müller, Horst;
    • Mettler, Jasmin;
    • Baues, Christian;
    • Fuchs, Michael;
    • Borchmann, Peter;
    • Ferdinandus, Justin;
    • Dietlein, Markus;
    • Voltin, Conrad‐Amadeus;
    • Kobe, Carsten;
    • Roth, Katrin S.
    Publication type:
    Article
    36

    JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 728, doi. 10.1111/ejh.13859
    By:
    • Gillessen, Sarah;
    • Pluetschow, Annette;
    • Vucinic, Vladan;
    • Ostermann, Helmut;
    • Kobe, Carsten;
    • Bröckelmann, Paul J.;
    • Böll, Boris;
    • Eichenauer, Dennis A.;
    • Heger, Jan‐Michel;
    • Borchmann, Sven;
    • Fuchs, Michael;
    • Borchmann, Peter;
    • Engert, Andreas;
    • von Tresckow, Bastian
    Publication type:
    Article
    37

    Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
    By:
    • Voltin, Conrad-Amadeus;
    • Paccagnella, Andrea;
    • Winkelmann, Michael;
    • Heger, Jan-Michel;
    • Casadei, Beatrice;
    • Beckmann, Laura;
    • Herrmann, Ken;
    • Dekorsy, Franziska J.;
    • Kutsch, Nadine;
    • Borchmann, Peter;
    • Fanti, Stefano;
    • Kunz, Wolfgang G.;
    • Subklewe, Marion;
    • Kobe, Carsten;
    • Zinzani, Pier Luigi;
    • Stelljes, Matthias;
    • Roth, Katrin S.;
    • Drzezga, Alexander;
    • Noppeney, Richard;
    • Rahbar, Kambiz
    Publication type:
    Article
    38

    Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 2, p. 490, doi. 10.1007/s00259-023-06431-w
    By:
    • Ferdinandus, Justin;
    • van Heek, Lutz;
    • Roth, Katrin;
    • Dietlein, Markus;
    • Eich, Hans-Theodor;
    • Baues, Christian;
    • Borchmann, Peter;
    • Kobe, Carsten
    Publication type:
    Article
    39

    How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 3, doi. 10.1007/s00259-023-06389-9
    By:
    • Ambrosini, Valentina;
    • Carrilho Vaz, Sofia;
    • Ahmadi Bidakhvidi, Niloefar;
    • Chanchou, Marion;
    • Cysouw, Matthijs C. F.;
    • Serani, Francesca;
    • Voltin, Conrad-Amadeus;
    • Kraeber-Bodere, Francoise;
    • Deroose, Christophe M.;
    • De Geus-Oei, Lioe-Fee;
    • Eiber, Matthias;
    • Gnanasegaran, Gopinath;
    • Gotthardt, Martin;
    • Kobe, Carsten;
    • Konijnenberg, Mark W.;
    • Nanni, Cristina;
    • Oprea Lager, Daniela E.;
    • Rahbar, Kambiz;
    • Taieb, David;
    • Mottaghy, Felix M.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Predictive value of early and late residual F-fluorodeoxyglucose and F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 7, p. 1117, doi. 10.1007/s00259-012-2118-8
    By:
    • Kobe, Carsten;
    • Scheffler, Matthias;
    • Holstein, Arne;
    • Zander, Thomas;
    • Nogova, Lucia;
    • Lammertsma, Adriaan;
    • Boellaard, Ronald;
    • Neumaier, Bernd;
    • Ullrich, Roland;
    • Dietlein, Markus;
    • Wolf, Jürgen;
    • Kahraman, Deniz
    Publication type:
    Article
    47
    48

    International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1343, doi. 10.2967/jnumed.124.267789
    By:
    • Boellaard, Ronald;
    • Buvat, Irène;
    • Nioche, Christophe;
    • Ceriani, Luca;
    • Cottereau, Anne-Ségolène;
    • Guerra, Luca;
    • Hicks, Rodney J.;
    • Kanoun, Salim;
    • Kobe, Carsten;
    • Loft, Annika;
    • Schöder, Heiko;
    • Versari, Annibale;
    • Voltin, Conrad-Amadeus;
    • Zwezerijnen, Gerben J.C.;
    • Zijlstra, Josée M.;
    • Mikhaeel, N. George;
    • Gallamini, Andrea;
    • El-Galaly, Tarec C.;
    • Hanoun, Christine;
    • Chauvie, Stephane
    Publication type:
    Article
    49

    Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 851, doi. 10.2967/jnumed.123.266979
    By:
    • Schuler, Martin;
    • Hense, Jörg;
    • Darwiche, Kaid;
    • Michels, Sebastian;
    • Hautzel, Hubertus;
    • Kobe, Carsten;
    • Lueong, Smiths;
    • Metzenmacher, Martin;
    • Herold, Thomas;
    • Zaun, Gregor;
    • Laue, Katharina;
    • Drzezga, Alexander;
    • Theegarten, Dirk;
    • Nensa, Felix;
    • Wolf, Jürgen;
    • Herrmann, Ken;
    • Wiesweg, Marcel
    Publication type:
    Article
    50